EXPOSED: The Connection Between Bill Gates and Jeffrey Epstein Centered on a Global Health Investment Fund

While Melinda has acknowledged that saving lives to reduce population may seem counterintuitive, it is not how she views the issue. “When more children live past the age of five,” she said in a 2018 interview, “population sizes don’t go up, they go down.”

Crucial to this formula are the population control efforts into which Bill and Melinda Gates and their foundation pour billions of dollars: contraceptives, pills, and abortion (or, as Melinda describes it, allowing mothers to “decide if and when to have children”).

The simple formula for Gates’s plan to save the world appeared to be the following: vaccines plus abortion plus birth control equals sustainability. As Controligarchs reveals, it just so happens that Bill Gates and his associates profit from both sides of this equation.

After JPMorgan and Gates teamed up on the global health fund, Epstein pitched an idea for a separate partnership, envisioning “a vast fund, seeded with the Gates Foundation’s money, that would focus on health projects around the world,” the New York Times reported.

However, any future plans involving Epstein were scrapped once he was charged with sex trafficking minors in July 2019. Naturally, his friends and associates began distancing themselves from him, and Melinda Gates claims that she divorced Bill in 2021 due to his relationship with Epstein. Bill Gates has denied having any involvement in Epstein’s crimes.

Epstein reportedly hung himself in his prison cell under mysterious circumstances in August 2019.

The GHIF continued its work after the Gates-JPMorgan-Epstein connections were exposed. It had backed mRNA technologies at least five years before the COVID-19 pandemic, and at least four of the companies that the GHIF invested in—Atomo Diagnostics, AccessBio, GeneDrive, and Univercells—“actively worked to address the COVID-19 pandemic through efficient diagnostics that help identify and track cases and the application of innovative technologies for vaccine development and manufacturing.”